tirzepatide nasal spray Weight Loss Injections Tirzepatide HypoSpray® | Topical GLP-1

Arturi F, Succurro E, Miceli S, Cloro C, Ruffo M, Maio R, et al

A triple-agonist research peptide (GIP / GLP-1 / glucagon) studied in the metabolic field

Early evidence suggests benefits in cardiovascular health, inflammation, and even neurological conditions

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes

- In the final Analysis, Bleaches the skin and lightens the scar

50 mg in 5 mL of liquid = 10 mg/mL 50 mg in 2.5 mL of liquid = 20 mg/mL 50 mg in 10 mL of liquid = 5 mg/mL Same total tirzepatide